Literature DB >> 825128

Inhibition of prostaglandin synthetase by tolmetin (Tolectin, McN-2559), a new non-steroidal anti-inflammatory agent.

R J Taylor, J J Salata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 825128     DOI： 10.1016/0006-2952(76)90452-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

Review 1.  Tolmetin: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

2.  Double-blind controlled trial to compare anti-inflammatory effects of tolmetin 2%, prednisolone 0.5%, and placebo in post-cataract extraction eyes.

Authors:  D L Smerdon; S O Hung; T Akingbehin
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

3.  Pharmacokinetic-pharmacodynamic modeling of tolmetin antinociceptive effect in the rat using an indirect response model: a population approach.

Authors:  F J Flores-Murrieta; H C Ko; D M Flores-Acevedo; F J López-Muñoz; W J Jusko; M E Sale; G Castañeda-Hernández
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

4.  Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis.

Authors:  B J Young; W F Cunningham; T Akingbehin
Journal:  Br J Ophthalmol       Date:  1982-06       Impact factor: 4.638

Review 5.  Zomepirac: a review of its pharmacological properties and analgesic efficacy.

Authors:  P A Morley; R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

6.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins.

Authors:  T M Penning; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 8.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

9.  Efficacy in anterior uveitis of two known steroids and topical tolmetin.

Authors:  J A Dunne; N Jacobs; A Morrison; D J Gilbert
Journal:  Br J Ophthalmol       Date:  1985-02       Impact factor: 4.638

Review 10.  Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.